PCK1 and metabolic syndrome: In addition to the many human GWAS hits for PCK1 noted above, human studies also identified a SNP in PCK1 that interacts with the plasma level of omega-3 polyunsaturated fatty acids in modulating insulin resistance in metabolic syndrome subjects [18].